ClinicalTrials.Veeva

Menu

Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis

S

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status

Enrolling

Conditions

Progressive Familial Intrahepatic Cholestasis
Cholestatic Liver Disease
Hepatobiliary Cancer
Intrahepatic Cholestasis

Study type

Observational

Funder types

Other

Identifiers

NCT06781242
3000468 (Other Grant/Funding Number)
Ad-FIC

Details and patient eligibility

About

Genotype-phenotype relationship between adult cryptogenic cholestasis and mutations in genes responsible for progressive familial intrahepatic cholestasis

Full description

Due to the high number of unsolved cases of adults with cholestatic liver disease, it is crucial to determine the prevalence of PFIC gene mutations and gather information on various clinical presentations that often coexist. This will help identify risk factors related to the disease and its progression, ultimately allowing for personalized treatment options for affected patients.

This multicenter, retrospective observational study will collect data on patients with cholestatic liver diseases (CCLDs) from May 2013 until the study begins. Diagnoses of PFIC/CCLD/HBC will be confirmed through imaging studies, excluding other liver disease causes.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age ≥ 18 years
  • diagnosis of PFIC/CCLDs/HBCs
  • obtaining informed consent

Exclusion criteria

  • Another documented cause of chronic liver disease capable of justifying the clinical phenotype

Trial contacts and locations

2

Loading...

Central trial contact

Giovanni Vitale, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems